Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00166296
What this trial is testing

Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients

Who this might be right for
Major Depressive DisorderHepatitis C, Chronic
Germans Trias i Pujol Hospital 133
Testing effectiveness (Phase 2)Study completedNCT00475176
What this trial is testing

S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Testing effectiveness (Phase 2)Study completedNCT00452023
What this trial is testing

Pegasys® in Patients With Myeloproliferative Diseases

Who this might be right for
Myeloproliferative Disorders
M.D. Anderson Cancer Center 83
Not applicableStudy completedNCT02508090
What this trial is testing

Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin

Who this might be right for
Chronic Hepatitis C
Hoffmann-La Roche 10
Testing effectiveness (Phase 2)Study completedNCT00984620
What this trial is testing

Short Term Treatment With BI 201335, Peginterferon-alpha 2a and Ribavirin in Hepatitis c Virus Genotype-1 Treatment-naïve Patients (SILEN-C3)

Who this might be right for
Hepatitis C
Boehringer Ingelheim 160
Large-scale testing (Phase 3)Study completedNCT01498068
What this trial is testing

Open-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis C

Who this might be right for
Genotype 1 Chronic Hepatitis C
Janssen-Cilag International NV 36
Not applicableWithdrawnNCT00876174
What this trial is testing

Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of Nebraska
Testing effectiveness (Phase 2)Ended earlyNCT00913913
What this trial is testing

Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients

Who this might be right for
Metastatic Renal Cell Carcinoma
Dartmouth-Hitchcock Medical Center 8
Large-scale testing (Phase 3)Study completedNCT02937285
What this trial is testing

National Multicenter, Controlled, Single-blind Study With Two Parallel Groups Evaluating the Safety and Efficacy of Sequential Treatment With Mitoxantrone and Interferon Versus Interferon Alone in Patients With Strong Risk of Progression in the Initial Phase of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Rennes University Hospital 35
Testing effectiveness (Phase 2)Study completedNCT00324389
What this trial is testing

Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood Lymphocytes

Who this might be right for
Hepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 2
Post-approval studies (Phase 4)Study completedNCT00001317
What this trial is testing

A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 100
Post-approval studies (Phase 4)Study completedNCT00179478
What this trial is testing

Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis

Who this might be right for
Multiple SclerosisOptic NeuritisTransverse Myelitis+1 more
Beth Israel Deaconess Medical Center 155
Testing effectiveness (Phase 2)Study completedNCT01605513
What this trial is testing

Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease

Who this might be right for
Hepatitis C Virus
The First Hospital of Jilin University 80
Large-scale testing (Phase 3)Study completedNCT00100659
What this trial is testing

PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 114
Testing effectiveness (Phase 2)Ended earlyNCT00176527
What this trial is testing

Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
University of Medicine and Dentistry of New Jersey 40
Large-scale testing (Phase 3)UnknownNCT01398618
What this trial is testing

Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)

Who this might be right for
Latent Tuberculosis Infection
National Taiwan University Hospital 300
Not applicableLooking for participantsNCT07769827
What this trial is testing

Peg IFNα-2b Therapy for Unresectable Mid to Late Stage HBV-HCC

Who this might be right for
HBV-HCCUnresectable Advanced HBV-related Liver Cancer
Jinling Hospital, China 33
Not applicableStudy completedNCT01122056
What this trial is testing

Effect of Aerobic Exercise on Side Effects of Disease Modifying Therapy With Subcutaneous Interferon-b1b in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of British Columbia 128
Early research (Phase 1)Study completedNCT01296451
What this trial is testing

Study of a New MVA Vaccine for Hepatitis C Virus

Who this might be right for
Hepatitis C Infection
ReiThera Srl 55
Large-scale testing (Phase 3)Study completedNCT01616524
What this trial is testing

Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3

Who this might be right for
Hepatitis C Virus (HCV)
Bristol-Myers Squibb 880
Next Page